Abstract
Membrane lipids have been implicated to influence the activity of G protein-coupled receptors (GPCRs). Almost all of our knowledge on the role of lipids on GPCR and G protein function comes from work on the visual pigment rhodopsin and its G protein transducin, which reside in a highly specialized membrane environment. Thus insight gained from rhodopsin signaling may not be simply translated to other non-visual GPCRs. Here, we investigated the effect of lipid head group charges on the signal transduction properties of the class A GPCR neurotensin receptor 1 (NTS1) under defined experimental conditions, using self-assembled phospholipid nanodiscs prepared with the zwitter-ionic lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), the negatively charged 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG), or a POPC/POPG mixture. A combination of dynamic light scattering and sedimentation velocity showed that NTS1 was monomeric in POPC-, POPC/POPG- and POPG-nanodiscs. Binding of the agonist neurotensin to NTS1 occurred with similar affinities and was essentially unaffected by the phospholipid composition. In contrast, Gq protein coupling to NTS1 in various lipid nanodiscs was significantly different and the apparent affinity of Gαq and Gβ1γ1 to activated NTS1 increased with increasing POPG content. NTS1-catalyzed GDP/GTPγS nucleotide exchange at Gαq in the presence of Gβ1γ1 and neurotensin was crucially affected by the lipid type, with exchange rates higher by one or two orders of magnitude in POPC/POPG- and POPG-nanodiscs, respectively, compared to POPC-nanodiscs. Our data demonstrate that negatively charged lipids in the immediate vicinity of a non-visual GPCR modulate the G protein-coupling step.
Keywords: G protein-coupled receptor, G protein, nanodisc, lipid, charge
Introduction
Biological membranes are barriers that separate inner compartments of cells from extracellular environments. Membranes not only provide the physiological environment for membrane proteins but they also modulate their function1,2. Membranes contain many different types of lipids3 in relative proportions that depend on the cell type and cellular compartments. Furthermore, changes in membrane lipid composition have been associated with age-related diseases4. Because the properties and geometry of lipid molecules dictate the membrane organization, lipid components directly impact the function of membrane proteins2. This aspect is especially important for membrane proteins that undergo conformational changes as part of their biological activity, as seen for GPCRs5,6. GPCRs are the most abundant superfamily of eukaryotic integral membrane proteins. They initiate signaling events for a wide variety of stimuli by selectively recognizing extracellular ligands and activating intracellular heterotrimeric G proteins at their inner side causing the release of GDP and the binding of GTP at the Gα subunit. Gα and Gβγ subunits then dissociate from the receptor and associate with downstream effectors. Arrestins, originally identified as negative regulators of G protein signaling, have been shown to act as adapters which promote distinct intracellular signals in their own right7.
Almost all studies on the influence of lipids on GPCR and G protein function have been performed with the visual pigment rhodopsin and its G protein transducin (see review8). However, the lipid composition of the rhodopsin containing rod outer segment (ROS) disc membranes is unique and different from that of plasma membranes8,9. The abundance of highly unsaturated acyl chains in its major phospholipids10 and high fluidity have been suggested to be crucial for anchoring of transducin and for rhodopsin activity. Given the unique lipid environment in which the components for visual signal transduction reside, conclusions inferred from rhodopsin signaling may not simply be transferred to other non-visual GPCRs.
Neurotensin (NT) is a tridecapeptide (pyroGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) found in both the nervous system and in peripheral tissues11,12. NT displays a wide range of biological activities and plays important roles in hypothermia13, antinociception14, cancer cell growth15, modulation of dopamine neurotransmission16, and Parkinson’s disease17. Three neurotensin receptors, NTS1, NTS2 and NTS3 have been identified; NTS118 and NTS219,20 belong to the class A GPCR family, whereas NTS3 (or sortilin) is a member of the Vps10p family which has a single transmembrane domain21. Most of the known effects of NT are mediated through NTS122,23, and targeting of NTS1 with synthetic agonists and antagonists for therapeutic purposes has been discussed22.
NTS1 binds NT at its extracellular surface24-26 and couples to a Gq-type G protein at its intracellular surface. These properties distinguish NTS1 from the well-studied rhodopsin and β-adrenergic receptors, which bind small ligands within their transmembrane (TM) cores and interact with Gi-type and Gs-type G proteins, respectively. Previously, we have studied the agonist-binding and G protein activation properties of NTS1 monomers and dimers in detergent solution27. In addition, the propensity of NTS1 to form dimers in a phospholipid bilayer has been investigated28. However, the effect of lipid molecules on the signaling properties of NTS1 has not yet been addressed.
In the present work, we investigate the effect of lipid charge on NT binding to NTS1 and activation of the Gq protein. In order to successfully carry out such studies, three essential conditions need to be met, namely (i) the lipid environment surrounding NTS1 has to be controlled with high precision, (ii) NT and the Gq protein must have simultaneous access to the extracellular and intracellular faces of NTS1, respectively, and (iii) the oligomeric state of NTS1 has to be well defined. A number of artificial systems such as vesicles or planar lipid membranes have been used to study GPCRs29. However, these approaches do not allow for control of receptor oligomerization and homogeneous accessibility of both intra- and extracellular receptor surfaces. In contrast, the “nanodisc” technology developed by Sligar and colleagues30 does satisfy all the criteria required for our experiment. A nanodisc is composed of 2 membrane scaffold protein (MSP) molecules stabilizing a planar phospholipid bilayer in which the target membrane protein resides. The nanodisc technique has previously been used to study various aspects of GPCR function31-39. To date, these have not been utilized to investigate the influence of lipid charge on the signaling process.
Here, we report on the incorporation of NTS1 monomers into nanodiscs composed of the zwitter-ionic lipid POPC, the negatively charged lipid POPG, or a mixture of POPC and POPG. We found that NT binding to NTS1 was largely unchanged in these 3 lipid environments; however, NTS1-catalyzed nucleotide exchange at Gq was markedly increased in the presence of negatively-charged lipids.
Results
Nanodisc reconstitution
The purpose of this study was to investigate the effect of phospholipid head-group charges on agonist and G protein interaction with the peptide receptor NTS1. All reconstitution experiments were conducted at 4°C or on ice to preserve NTS1 activity. We utilized the zwitterionic POPC and negatively charged POPG, both of which have phase transition temperatures below 0°C40,41 and a cylindrical molecular shape42. POPG (although a minor phospholipid in eukaryotic membranes42) was chosen instead of the more abundant 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine with a higher transition temperature of 14°C43. All nanodisc reconstitution experiments were conducted using either zwitterionic POPC, a mixture of POPC/POPG at a molar ratio of 1:1, or negatively charged POPG. First, we established the reconstitution procedure for nanodiscs without receptor (empty-nanodiscs) in small-scale preparations by optimizing the lipid to N-terminally truncated membrane scaffold protein 1 (MSP1D1) ratio and found that a 55:1 molar ratio of lipid to MSP1D1 resulted in well-defined nanodiscs having hydrodynamic radii of 4.7-5.2 nm (Table 1) in agreement with previously published data30.
Table 1.
Dynamic light scattering and sedimentation velocity experiments.
| Sample | Dynamic light scattering |
Sedimentation velocity | |||
|---|---|---|---|---|---|
| Rh,1 (nm)a | s20,w (S)b | Mexp (kDa)b | % load, c (μM)c |
Lipidd (εJ/ε280) |
|
| Empty-nanodisc | |||||
| POPC | 4.7 | 2.88 ± 0.01 | 155 ± 8 | 91 (20) | 114 |
| POPC/POPG | 5.2 | 3.22 ± 0.01 | 174 ± 9 | 88 (17) | 139 |
| POPG | 5.1 ± 0.3 | 3.66 ± 0.02 | 199 ± 13 | 91 (20) | 102 |
| NTS1f-nanodisc | |||||
| POPC | 6.2 ± 0.5 | 6.49 ± 0.02 | 204 ± 6 | 81 (3.7) | 63 |
| POPC/POPG | 6.4 ± 0.5 | 6.66 ± 0.02 | 211 ± 7 | 79 (3.6) | 105 |
| POPG | 6.6 ± 0.8 | 6.85 ± 0.02 | 208 ± 5 | 64 (2.7) | 52 |
Data were analyzed in terms of two discrete species (empty-nanodiscs) or a second moment cumulant (NTS1f-nanodiscs). The hydrodynamic radii (Rh,1) values were calculated from the average of independent experiments (± SD) (empty-nanodiscs: POPC, n=1; POPC/POPG, n=2; POPG, n=2; NTS1f-nanodiscs: POPC, n=3; POPC/POPG, n=2; POPG, n=2). In addition to monodisperse species, a minor population of aggregates (Rh,2 > 100 nm) was found in empty-nanodisc (but not in NTS1f-nanodisc) preparations.
Sedimentation coefficients [s20,w (S)] and experimental molecular masses (Mexp) represent average values for the major species observed in the continuous c(s) distribution in a single experiment for each nanodisc preparation. Averages and errors (± SD) were obtained from both the absorbance and interference data analyzed using a continuous c(s) distribution in SEDFIT, as well as various hybrid local continuous distributions and global discrete species models in SEDPHAT.
Percent of the loading absorbance that represents the major species of interest, based on the best-fit continuous c(s) distribution observed with SEDFIT. The observed concentration c of the major nanodisc species is indicated in brackets.
Lipid stoichiometries per single nanodisc based on the presence of 2 MSP1D 1 molecules, and in the case of the receptor-nanodiscs, 1 NTS1f molecule. Stoichiometries are based on signal contributions of the major species to the absorbance (protein alone) and interference (protein and lipid) data.
An overview for NTS1 reconstitution into nanodiscs is shown in Fig. 1. For this, we used the NTS1 fusion protein (NTS1f)44 consisting of the Escherichia coli maltose-binding protein (MBP), followed by a tobacco etch virus (Tev) protease recognition site, the rat NTS1, a second Tev protease recognition site at the receptor C terminus, the E. coli thioredoxin (TrxA) and a decahistidine tag (H10). Based on the above results with empty-nanodiscs, initial reconstitutions with NTS1f were conducted at a 55:1 lipid:MSP1D1 molar ratio and an excess of MSP1D1 to receptor (110:~4 MSP1D1:NTS1f molar ratio) to favor assembly of single NTS1f molecules34,36. However, this procedure resulted in large particles having diameters of 35-50 nm (data not shown) rather than defined nanodiscs, indicating that the ratio of the lipid to protein components was far from ideal45. Therefore, we optimized the NTS1f-nanodisc procedure by using lipid:MSP1D1 and MSP1D1:NTS1f molar ratios of 30:1 and 110:~4, respectively, in the initial reaction setup. After incubation and detergent removal using Bio-Beads, we obtained a mixture of nanodiscs containing NTS1f (NTS1f-nanodiscs) and nanodiscs without receptor. The receptor-nanodiscs were purified by subsequent affinity chromatography (Talon resin) exploiting the H10-tag of NTS1f (Fig. 1). The NTS1f-nanodiscs, generated with POPC, POPC/POPG and POPG, had hydrodynamic radii, which were slightly larger than those of the empty-nanodiscs (Fig. 2 and Table 1) and similar to those reported for nanodiscs containing monomeric rhodopsin32,37, β2-adrenergic receptor35,36, and μ-opioid receptor34.
Fig. 1.
Preparation of NTS1-nanodiscs. (a) The reconstitution reactions were carried out using MSP1D1, cholate-dissolved lipids, and NTS1f. After detergent removal, nanodiscs without NTS1f were separated from NTS1f-nanodiscs by immobilized metal affinity chromatography exploiting the H10 tail of the receptor fusion protein. Purified NTS1f-nanodisc was treated with Tev protease prior to ligand binding and nucleotide exchange experiments, to generate the NTS1-nanodisc. (b) Samples of the reconstitution and purification steps were analyzed by SDS-PAGE (4 μg protein/lane). Lane 1: Perfect Protein Markers (15-150 kDa) from Novagen; lane 2: MSP1D1; lane 3: purified NTS1f; lane 4: mixture after detergent removal by Bio-Beads; lane 5: Talon column flow-through containing nanodiscs without NTS1f; lane 6: Talon resin eluate containing purified NTS1f-nanodiscs; lane 7: NTS1-nanodiscs after treatment of NTS1f-nanodiscs with Tev protease. The SDS-gel shown here was from a reconstitution reaction using POPC. Reconstitutions with POPC/POPG and POPG gave similar results.
Fig. 2.
DLS analysis of nanodiscs. (a) DLS autocorrelation functions for empty-nanodiscs reconstituted with POPC (blue), POPC/POPG (green) and POPG (red) are best modeled in terms of contributions from two discrete species corresponding to empty-nanodiscs (Rh,1) and traces of aggregates (Rh,2). The autocorrelation function is shown along with the best-fit two species model and corresponding residuals. (b) DLS autocorrelation functions for NTS1f-nanodiscs prepared using POPC (blue), POPC/POPG (green) and POPG (red) are best modeled in terms of a paucidisperse species. The autocorrelation function for a batch of NTS1f-containing POPC-MSP1D1 nanodisc is shown along with the best-fit using a quadratic cumulant and corresponding residuals. Data for these preparations of the POPC/POPG and POPG nanodiscs practically superimpose.
A single NTS1 is reconstituted into receptor-nanodiscs
To determine whether a single monomeric NTS1f was reconstituted in the receptor-nanodiscs, we characterized NTS1f- and empty-nanodisc preparations by dynamic light scattering (DLS), sedimentation velocity, and lipid analyses. First we characterized empty-nanodiscs, reconstituted using MSP1D1 and various lipids, by a combination of sedimentation velocity and DLS in order to establish the validity of these methods. Sedimentation velocity experiments indicated the presence of a major species at 2.9-3.7 S, depending on the lipid composition (Fig. 3a and Table 1). These observations are in agreement with DLS studies that indicate the presence of a major species having a hydrodynamic radius (Rh,1) of ~ 5 nm (Fig. 2a, Table 1), along with minute quantities of a larger aggregate (Rh,2 > 100 nm). We note that the sedimentation coefficient of the empty-nanodisc reconstituted using combinations of POPC and POPG increases with increasing POPG content, reflecting in part the increased molecular mass of this lipid and possibly a smaller partial specific volume for POPG. The best-fit frictional ratios f/fo of 1.2-1.3 obtained from the c(s) analysis are consistent with the overall shape of the empty-nanodiscs; however, we find that the best-fit molecular masses for the major species are larger than expected based on a lipid:MSP1D1 ratio of 55:1. In a manner analogous to methods developed for the study of membrane proteins in the presence of solubilizing detergents46,47, we combined the absorbance and interference signal intensities for the major species to determine the lipid to protein content (Table 1). Briefly, the absorbance signal for the species of interest, obtained from an integration of the c(s) distribution, was used to determine the MSP1D1 concentration. The corresponding contribution of MSP1D1 to the interference signal is then used to determine the lipid concentrations. We found that stoichiometries of 102 to 139 lipid molecules per empty-nanodisc were consistent with expectations45, and note that these determinations are based solely on the signal intensities and made independent of any assumptions regarding the molecular mass and partial specific volumes.
Fig. 3.
Sedimentation velocities analysis of nanodiscs. (a) Sedimentation velocity c(s) distributions obtained in SEDFIT for empty-nanodiscs reconstituted with POPC (blue), POPC/POPG (green) and POPG (red) based on interference data. (b) c(s) distributions obtained in SEDFIT for NTS1f-nanodiscs reconstituted with POPC (blue), POPC/POPG (green) and POPG (red) based on interference data. Besides the major species, a small contribution is observed at lower and higher S values, possibly representing small amounts of free MSP1D1 or empty-nanodiscs, and aggregated NTS1f-nanodiscs, respectively. Data were collected at 40 krpm and 10.0°C.
As in the case of the empty-nanodiscs, the purified NTS1f-nanodiscs were characterized using a combination of analytical ultracentrifugation and DLS. Sedimentation velocity experiments showed the presence of a major species of 6.5-6.9 S depending on the lipid composition (Fig. 3b and Table 1), and a small amount of higher mass impurities (~9 S) (Fig. 3b). These observations are in broad agreement with DLS studies that indicate the presence of species having an average hydrodynamic radius of 6.2-6.6 nm (Fig. 2b and Table 1). DLS studies further indicate that the higher mass impurities present appear to be preparation dependent – for example, three separate preparations of POPC receptor-nanodiscs lead to best-fit average hydrodynamic radii of 5.7, 6.3 and 6.7 nm. The corresponding polydispersity indices (μ2/Γ2) increased with the hydrodynamic radius, reflecting an increasing contribution from the higher mass species (data not shown). Even though DLS does not resolve the contributions from the various species, sedimentation velocity does, allowing us to characterize the major receptor-nanodisc complex. Molecular masses for the major species, derived from the best-fit frictional ratio f/fo of 1.3-1.4 are consistent with a monomer NTS1f-nanodisc (Table 1). To further confirm that a single NTS1f molecule is reconstituted into the 6.5-6.9 S nanodiscs, we used the absorbance and interference signal contributions of the major species to determine the lipid stoichiometry. We found 52-105 lipid molecules per NTS1f-nanodisc depending on the lipid composition (Table 1), in broad agreement with determinations of the lipid content by HPLC/MS/MS and 1H-NMR (Table 2). The lipid numbers determined by 1H-NMR (Table 2) may represent a slight underestimate due to the techniques involved in sample preparation (see experimental section). In addition, we note that the observed higher lipid content of NTS1f-POPC/POPG-nanodiscs (Table 1) is possibly an outlier (one sedimentation velocity experiment was performed for each nanodisc preparation) as the lipid content determined by 1H-NMR is similar for all 3 types of receptor-nanodiscs (Table 2).
Table 2.
Determination of nanodisc lipid content by HPLC/MS/MS and 1H-NMR. The number of lipid molecules per empty-nanodisc are based on the presence of 2 MSP1D1 molecules, and in the case of the receptor-nanodiscs, on 1 NTS1f molecule.
| HPLC/MS/MS | 1H-NMR | |
|---|---|---|
| Empty-nanodisc | ||
| POPC | 141 | 95a |
| POPC/POPG | n.d. | 85a |
| POPG | n.d. | 92a |
| NTS1f-nanodisc | ||
| POPC | 66 | 55a |
| POPC/POPG | n.d. | 44a |
| POPG | n.d. | 67a |
The lipid content by 1H-NMR may represent an slight underestimate due to potential sample losses during the filtration step required for sample preparation. The data on lipid content from sedimentation velocity experiments are shown in Table 1. n.d., not determined.
These observations support the presence of 1 NTS1f molecule and 2 MSP1D1 molecules per receptor-nanodisc; they do not support the presence of 2 NTS1f molecules in a single nanodisc. In the determination of the lipid content using the absorbance and interference signal intensities (Table 1), we assumed the presence of two MSP1D1 and one NTS1f per nanodisc. Assuming the presence of two NTS1f molecules per nanodisc leads to calculated lipid stoichiometries (POPC: 133 lipid molecules per nanodisc, POPC/POPG: 210, POPG: 120) that exceed that of the empty-nanodiscs (Table 1). As the hydrodynamic radii of the NTS1f-nanodiscs reflect the z-average of the preparation (major species and a small amount of higher mass impurities), the radii of the major species are expected to be slightly smaller than the values reported. As the excess amount of lipid and NTS1f would be difficult to accommodate into a nanodisc just slightly larger than an empty-nanodisc, it is unlikely that these nanodiscs contain more than a single NTS1f.
Furthermore, simple volume and shape calculations48,49 based on an f/fo of 1.35, return an expected sedimentation coefficient of 6.45 S for a receptor-nanodisc having a stoichiometry of 60:2:1 POPC:MSP1D1:NTS1f (see Table 1). Corresponding calculations made for a dimeric receptor-nanodisc with a stoichiometry of 10:2:2 (whereby we assumed that 1 NTS1f molecule displaces 50 lipid molecules32) returns a sedimentation coefficient of 10.1 S. Based on this, and the experimental lipid stoichiometry as estimated from the absorbance and interference signal intensities, the higher mass impurities observed at ~9 S (Fig. 3b) are unlikely to represent receptor-nanodiscs containing two NTS1f molecules. Importantly, the calculated S value of 10.1 contrasts with the experimentally determined S values of 6.5-6.9 for the major species suggesting that the NTS1f-nanodiscs contain only 1 receptor molecule.
Negatively charged lipids modulate nucleotide exchange at Gαq, but not NT binding to NTS1
NTS1f-nanodiscs were treated with Tev protease prior to ligand binding and nucleotide exchange experiments, to remove the MBP and TrxA-H10 tags and thus generate NTS1 with near authentic N- and C-termini (Fig. 1 and Fig. 4).
Fig. 4.
Nucleotide exchange at Gαq requires a near authentic receptor C-terminus. GDP/35S-GTPγS exchange experiments were conducted with POPC-nanodiscs containing NTS1f in the presence and absence of Tev protease. Increased 35S-GTPγS binding was observed after cleaving off the C-terminal affinity tag. Two similar experiments in duplicates were performed for each test; one representative experiment is shown.
To assess whether agonist binding to NTS1 is affected by the various lipid compositions used for the nanodisc preparations, 3H-neurotensin (3H-NT) saturation binding and 3H-NT/NT homologous competition experiments were conducted in the absence of G protein (representative experiments are shown in Fig. 5). Data from saturation experiments were best fit to a one-site binding equation; the corresponding Kd values for POPC, POPC/POPG, and POPG were similar (Table 3). Likewise, the data from homologous competition experiments were best fit to a sigmoidal dose-response equation with a standard slope of 1, and the corresponding IC50 values were also comparable. The calculated Ki values matched the corresponding Kd values obtained from saturation binding experiments. To assess whether agonist binding to NTS1 in the presence of Gq protein is affected by the lipid composition, we conducted dose-response experiments (NT saturation of NTS1-catalyzed GDP/GTPγS exchange, Fig. 5d-f) by varying the concentration of NT and recording nucleotide exchange at Gαq. Consistent with the homologous competition experiments, the EC50 values for NT-stimulated activation of Gαq by NTS1 were also similar and independent of the lipid composition (Table 3). Altogether, these results suggest that the nanodisc lipid compositions did not substantially modulate agonist binding to NTS1.
Fig. 5.
Pharmacological properties of NTS1 in nanodiscs. (a)-(c) Saturation binding experiments: 3H-NT binding to NTS1 incorporated into nanodiscs prepared using POPC (a), POPC/POPG (b), and POPG (c). A one-site binding equation was used for curve fitting. (Inset) Scatchard transformation with B/F = bound/free. (d)-(f) Homologous competition and agonist-stimulated activation of Gαq: 3H-NT/NT competition experiments in the absence of G protein are shown for NTS1-nanodiscs prepared with POPC (d), POPC/POPG (e), and POPG (f) [● (grey circles), total NT added (x axis) vs. total 3H-NT displaced (right y axis). Agonist-stimulated activation of Gαq: 35S-GTPγS binding was recorded in response to the indicated amounts of NT in the presence of Gαq and Gβ1γ1 [■, total NT added (x axis) vs. total 35S-GTPγS bound (left y axis)]. Data were best fit to equations with a Hill slope of 1. Note that the nucleotide exchange reactions proceeded for 120 min, 45 min and 15 min in the case of POPC-, POPC/POPG- and POPG-nanodiscs, respectively. One representative experiment for each is shown.
Table 3.
Pharmacological properties of NTS1 in nanodiscs. All values are given ± SD. Kd , equilibrium dissociation constant (saturation binding); IC50, half maximal inhibitory concentration (homologous competition); Ki , dissociation constant calculated by the Cheng and Prusoff equation; EC50, half maximal effective concentration (NT saturation of Gαq activation); Km, binding constants for Gαq and Gβ1γ1 (Gαq and Gβ1γ1 saturation); normalized data from Gαq, Gβ1γ1 and NT saturation experiments on ice given as catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1 are the average from the respective experiments. n, number of independent experiments; n.d., not determined.
| POPC | POPC/POPG | POPG | |
|---|---|---|---|
| Kd (nM) | 1.04 ± 0.46 (n=3) | 0.24a (n=2) | 0.31 ±0.11 (n=3) |
| Ki (nM) | 1.16 ± 0.02 (n=4) | 0.24 ± 0.04 (n=4) | 0.35 ± 0.03 (n=3) |
| IC50 (nM) | 3.46 ± 0.07 (n=4) | 2.34 ± 0.36 (n=4) | 2.66 ± 0.24 (n=3) |
| EC50 (nM) | 4.92 ± 1.33 (n=3) | 4.54 ± 0.94 (n=3) | 3.05 ± 0.41 (n=3) |
| Km Gαq (μM) | n.d. (n=2) | > 5 (n=3) | 0.55 ± 0.07 (n=3) |
| Km Gβ1γ1 (μM) | n.d. (n=2) | 8.2±4.3 (n=4) | 2.40±0.12 (n=4) |
| Normalized data [catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1] | |||
| Gαq saturation | 21b (n=2) | 656 ±166 (n=3) | 3496 ± 50 (n=3) |
| Gβ1γ1 saturation | 11c (n=2) | 280 ±174 (n=4) | 2784 ±170 (n=4) |
| NT saturation | 45 ± 30 (n=3) | 2177±548 (n=3) | 7392 ±1288 (n=3) |
average value of 0.21 and 0.26 nM
average value of 17 and 25 catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1
average value of 8 and 13 catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1
In contrast to NT binding, G protein activation was dramatically affected by the nature of the lipid present in the respective nanodiscs (Fig. 6 and Table 3). Even though Gαq (but not Gβ1γ1) is prepared using the detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS), the integrity of the nanodiscs is not affected by this as the highest Gαq concentration used in the nucleotide exchange assays was 1 μM, thus limiting the free CHAPS concentration in the exchange reactions to less than 1/10th of its critical micellar concentration50.
Fig. 6.
Gαq (a) and Gβ1γ1 (b) saturation of NTS1-catalyzed GDP/GTPγS exchange. 35S-GTPγS binding was measured in reactions containing NTS1-nanodiscs with POPC (blue), POPC/POPG (green) and POPG (red), respectively. The fractional contribution of non-catalyzed nucleotide exchange at a given Gαq or Gβ1γ1 concentration was estimated in the absence of NT and subtracted from total 35S-GTPγS binding. Normalization of the data to catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1 [Gαq (c) and Gβ1γ1 (d) saturation] emphasizes the effect of POPG on the nucleotide exchange reaction. One representative experiment for each is shown.
The Gαq saturation experiments of NTS1-catalyzed nucleotide exchange were carried out by holding the Gβ1γ1, NT, and NTS1 concentrations constant (at 1 μM, 10 μM, and 5 nM, respectively) and varying the concentration of Gαq (Fig. 6a). For NTS1-POPG-nanodiscs, we determined a robust Km (Gαq) value in the sub-micromolar range (Table 3). A Km value could not be reliably calculated for the NTS1-POPC/POPG-nanodiscs because of the low affinity. Similarly, we were unable to determine a Km value for the NTS1-POPC-nanodiscs because the exchange reactions were too slow to measure under our experimental conditions. Gβ1γ1 saturation experiments of NTS1-catalyzed nucleotide exchange were done by holding the concentrations for Gαq, NT, and NTS1 at 250 nM, 10 μM, and 5 nM, respectively, and varying the concentration of Gβ1γ1 (Fig. 6b). The Km (Gβ1γ1) value for POPG was found to be 3-fold lower than that for POPC/POPG (Table 3). As for Gαq, the Km (Gβ1γ1) for NTS1-POPC-nanodiscs could not be determined because the reactions were too slow. Taken together, our data correlate an apparent affinity increase with the presence of POPG in NTS1-nanodiscs. The effect of the negatively charged lipid POPG on the NTS1-catalyzed nucleotide exchange was seen even clearer when normalizing nucleotide exchange rates at the highest Gαq (1 μM), Gβ1γ1 (5 μM), and NT (1 μM) concentrations used in the respective Gαq (Fig. 6a), Gβ1γ1 (Fig. 6b), and NT (Fig. 5d-f) saturation assays [catalyzed 35S-GTPγS bound in cpm (nM NTS1 protein)−1 min−1]. Compared to NTS1-POPC-nanodiscs, normalized nucleotide exchange rates are increased in all cases by one and two orders of magnitude for NTS1-POPC/POPG- and NTS1-POPG-nanodiscs, respectively (Table 3). Likewise, normalization of the data in Fig. 6a and 6b emphasized the effect of POPG (Fig. 6c and 6d). The results clearly indicate that the Gq protein apparent affinity to NTS1 and nucleotide exchange rates increase in the presence of negatively charged lipids.
Discussion
The importance of phospholipids for the conformational energetics of rhodopsin and activation of transducin has been well documented8,51-57. However, rhodopsin represents an unusual case with respect to receptor-lipid interactions8, and lessons learned from rhodopsin signaling may not be simply extrapolated to other GPCRs. Here, we investigated the effect of lipid head group charges on the signal transduction properties of the Gq-coupled peptide receptor NTS1 embedded into nanodiscs containing the zwitterionic lipid POPC, or the negatively-charged lipid POPG, or a mixture of the two. We show that an increasing negative charge density dramatically affects the NTS1-catalyzed GDP/GTPγS nucleotide exchange rates for Gαq, whereas agonist binding shows little influence by the surrounding lipid type. Of interest, it has been shown that the interaction of arrestin with rhodopsin, reconstituted into nanodiscs, was enhanced in the presence of phospholipids with acidic head groups58,59.
The following observations support the notion that NTS1-nanodiscs contain a single receptor molecule. NTS1f was prepared in buffer containing detergent at concentrations that render the receptor monomeric before reconstitution27,44. The initial reconstitution mixture contained an excess of MSP1D1 over NTS1f, which favors the incorporation of a single receptor molecule per nanodisc34-37. Sedimentation velocity data and lipid analyses support the presence of 1 NTS1f molecule and 2 MSP1D1 molecules per receptor-nanodisc, but not 2 receptor molecules. Furthermore, data from 3H-NT saturation and competition experiments were best fit to equations with a Hill slope of 1, as opposed to Hill slopes of 2 we have previously observed for dimeric NTS1 in detergent solution27, consistent with one NTS1 molecule per nanodisc.
The experimentally determined average lipid content in NTS1f-nanodiscs is ~65 molecules (Tables 1 and 2) likely providing one layer of lipid molecules around NTS1. A similar number was found for rhodopsin in ROS membranes [65-75 phospholipids per rhodopsin monomer60,61]. The lipid content in NTS1-nanodiscs is lower than that found in nanodiscs containing monomeric rhodopsin (196 POPC molecules, determined by phosphate analysis32). This difference is likely due to the use of the smaller MSP1D1 in our study, rather than the MSP1E3D1 utilized in the rhodopsin study32, which leads to the formation of a larger disc and hence incorporation of more lipid62. As in our studies, Leitz and colleagues report the presence of ~100 POPC molecules for a β2-adrenergic receptor nanodisc constructed with MSP135. Note that other reports on GPCR-nanodiscs31,33,34,36,37 state the lipid:membrane scaffold protein:receptor ratios in the initial reaction mixtures, but do not report an experimentally determined lipid content for the purified receptor-nanodiscs.
Both POPC (a zwitter-ionic lipid with neutral electrical surface potential) and POPG (negatively charged) are classified as cylindrical in shape42; hence the observed effects must relate to differences in charge properties rather than to their packing within the NTS1-nanodiscs. The agonist binding and nucleotide exchange experiments were conducted at 0-4°C. Although pure POPC and POPG have transition temperatures below 0°C (POPC: −2.6°C41, POPG: −4.0°C40), we have no experimental data on the phase behavior of POPC and POPG in NTS1-nanodiscs. A study of the phase transition properties of the lipids di-palmitoyl-phosphatidylcholine and di-myristoyl-phosphatidylcholine in empty-nanodiscs revealed a shift of the transition midpoint to higher temperature compared to vesicles, reflecting a more ordered state of the lipids in close contact with MSP compared to “core” lipids63,64. Hence the close contact of POPC and POPG with MSP1D1 and NTS1 may well alter their properties.
Studies of lipid influence on rhodopsin signaling have suggested a number of mechanisms including bilayer curvature elastic stress, dynamics of annular lipids, membrane thickness, rhodopsin-rhodopsin interactions, electric membrane surface potential, and cholesterol concentration56. In our study, we can eliminate NTS1 dimerization and bilayer elastic stress as an explanation as our nanodiscs contain one NTS1 molecule, surrounded by one layer of lipid. In addition, the rapid exchange of annular lipids with bulk lipid observed in vesicles56 is not given in nanodiscs. Hence the strong effect of the negatively-charged POPG on G protein affinity and nucleotide exchange rates may arise from a combination of the following mechanisms: Partitioning of G protein components to the receptor-nanodiscs, specific interactions between lipid and receptor residues, and local net charges at the NTS1/lipid interface.
Upon combining NTS1-nanodiscs with G protein components, the assembly mixture contains G protein heterotrimers, excess Gβ1γ1, NTS1, and no free Gαq. Initial binding of Gαq/Gβ1γ1 and Gβ1γ1 to receptor-nanodiscs occurs under conditions of rapid equilibrium. After addition of the GDP/35S-GTPγS mix, Gαq with bound 35S-GTPγS dissociates from NTS1 and Gβ1γ1. At this point in the exchange reactions, the precise stoichiometries of Gαq and Gβ1γ1 bound to the receptor are unknown, as our exchange assays measure turnover rates, not stoichiometries. Therefore, we cannot at this time strictly allocate the observed effects of lipid charge to partitioning of GαqGβ1γ1 and Gβ1γ1 to nanodiscs, or direct activation of GαqGβ1γ1 by NTS1, despite discussing these aspects separately.
It has been found that membrane association of the transducin heterotrimer with negatively-charged phosphatidyl-serine vesicles occurs with somewhat lower affinity compared to partitioning into phosphatidyl-choline vesicles65,66, suggesting that negative charge is not a major driving force for the partitioning of the Gαq/Gβ1γ1 heterotrimer to NTS1-nanodiscs. In contrast, membrane association of Gβ1γ1 is driven in part by electrostatic effects67-69 (and by hydrophobic effects via the farnesyl modification at the C-terminus of the Gγ1 subunit), and a modest increase of Gβ1γ1 binding to model membranes containing negatively charged lipids has been reported65,66. Overall, the effect of lipid charge on the partitioning of G protein components to the receptor-nanodiscs seems not sufficient to solely explain the observed increase in nucleotide exchange rates.
Recently, specific interactions between lipids and protein residues have been suggested to influence membrane protein function1 with lipid molecules binding into clefts between helices, affecting the way helices pack into bundles. Hypothetically, such lipid-induced conformational changes in GPCRs (as opposed to the effect of bilayer curvature elastic stress) could affect G protein activation. It has been proposed that the molecular properties of lipids in the annular lipid layer surrounding rhodopsin are important for the MI-MII equilibrium70, and evidence for the specific interaction of lipid with rhodopsin in different conformational states has been reported71-74. Furthermore, a cholesterol-binding site has been established for the β2-adrenergic receptor75. In the case of NTS1, additional experiments are needed to determine whether POPG triggers conformational changes.
The actual surface potential at the NTS1/lipid interface is unknown because bivalent cations, present in the nucleotide exchange reaction, interact with the negatively charged lipid phosphate groups, and because the concentration of Na+ ions possibly changes with increasing amounts of POPG. In addition, it has been proposed that a negative surface potential leads to accumulation of hydronium ions57. This may favor the protonation of Glu-166 of the conserved E(D)RY motif in NTS1, and hence the productive interaction with the G protein56,76-78 in POPG-containing NTS1-nanodiscs.
In conclusion, our studies carried out under carefully controlled experimental conditions with the Gq coupled peptide receptor NTS1, show that the overall conformation of the NT binding site is little influenced by the lipid type, while the lipid charge in the immediate vicinity of NTS1 exerts a strong influence on the Gq protein interaction. As the lipid composition differs from tissue to tissue, and even within a single cell membrane, variation of lipids in the immediate vicinity of NTS1 may provide a mechanism to regulate cell-specific NTS1 signaling in addition to desensitization and downregulation.
Materials and Methods
Materials
The tritiated agonist 3H-NT ([3,11-tyrosyl-3,5-3H(N)]-pyroGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) was purchased from Perkin Elmer. Unlabeled NT was synthesized by the Center for Biologics Evaluation and Research (Food and Drug Administration). The detergents n-dodecyl-β-D-maltopyranoside, CHAPS, sodium cholate, and cholesteryl hemisuccinate Tris salt were obtained from Anatrace. The lipids POPC and POPG were purchased from Avanti Polar Lipids. The Tev protease mutant His-Tev(S219V)-Arg was essentially prepared as reported44,79.
NTS1 expression and purification
The rat NTS1 fusion protein (NTS1f) (MBP-N10-Tev-rT43NTR-CH2-N5G3S-G3S-TrxA-H10) consists of MBP, followed by a linker and a Tev protease recognition site, the N-terminally truncated rat NTS1 starting at Thr43, a second Tev protease recognition site at the receptor C terminus, a linker, TrxA and a H10 tag. The NTS1 fusion protein was produced in E. coli and purified as described44. To obtain receptor devoid of MBP and affinity tag, the fusion protein was incubated with Tev protease to generate NTS1 with Ser-Gly-Ser at the N terminus and with the C terminus ending in Glu421-Asn-Leu-Tyr-Phe-Gln.
Preparation of Gαq and Gβ1γ1
Cephalopod Gαq was purified from dark-adapted retinas of Sepia officinalis as described80. The final Gαq concentration was 10 μM in a buffer containing 10 mM MOPS, pH 7.4, 100 mM NaCl and 4 mM CHAPS.
The heterodimer of bovine transducin Gtβγ (Gβ1γ1) was purified as follows. Bovine ROS discs were isolated from frozen dark-adapted bovine retina obtained from W. Lawson, Inc. by a modification of the sucrose density gradient method of Papermaster and Dryer81. All solutions used were as described previously82, but instead of layering the 45% sucrose floated outer segment fraction on multistep gradients, the ROS disc fraction was isolated by two sequential single-step gradients. Briefly, the pelleted outer segment fraction was resuspended in a 34% sucrose solution, and adjusted to 34% sucrose with a 60% sucrose solution. 25 ml of that suspension was overlayered with 10 ml of a 25% sucrose solution for centrifugation at 27,000 rpm for 30 min in a Beckman SW28 rotor. The 26%/34% interface was harvested, diluted with 1.5 volumes of PEMD buffer [10 mM sodium phosphate pH 7.5, 1 mM ethylenediaminetetraacetate (EDTA), 2 mM MgCl2, 1 mM dithiothreitol (DTT)] and collected by sedimentation for 30 min at 20,000 rpm in a Beckman JLA25 rotor. The pellets were resuspended in a 26% sucrose solution and adjusted to 26% sucrose with 60% sucrose, and 20 ml were layered over 15 ml of 30% sucrose for centrifugation at 27,000 rpm for 30 min in a SW28 rotor. The 26%/30% interface was collected by dilution with 1.5 volumes of PEMD buffer and sedimented for 30 min at 20,000 rpm in a JLA25 rotor. The final ROS disc pellet was resuspended with 12% sucrose in PEMD buffer for storage at -80°C.
Transducin was isolated from light-exposed ROS disc membranes by the method of Kuhn83, and Gtα and Gβ1γ1 were resolved by chromatography over Affigel-Blue Agarose by a modification of the method of Yamazaki and Bitensky84. Briefly, instead of collecting sequential washes of increasing NaCl concentrations, the GTP-eluted transducin heterotrimer was applied to a 25 ml bed-volume column of Affigel-Blue (Bio-Rad), and was eluted with a segmented gradient of NaCl (100-300 mM NaCl for 8 bed volumes, 300-1000 mM NaCl for 3 bed volumes). The bulk of the Gtα was adsorbed and eluted at 500 mM NaCl, free of Gβ1γ1. The heterodimer Gβ1γ1 was largely found in the flow-through, and residual contaminating Gtα was removed by re-chromatography with the same procedure. The final Gβ1γ1 concentration was 25 μM in buffer containing 10 mM MOPS and 1 mM DTT.
Preparation of MSP1D1
The expression plasmid pMSP1D1 (# 20061, Addgene) is a derivative of pET28a and codes for the synthetic gene of the deletion mutant (Δ1-54) of the human Apolipoprotein A-I, preceded by an N-terminal heptahistidine tag (H7), spacer sequence, and Tev protease recognition site (H7-MSP1D1)62. Expression was carried out as described62 with modifications. BL21Gold(DE3) cells (Stratagene) harboring pMSP1D1 were grown at 37°C in double strength TY medium containing 50 μg/ml kanamycin to an OD600 of 4. After induction with 0.3 mM isopropyl-β-D-thiogalactopyranoside, the temperature was decreased to 28°C. The cells were harvested 4 hours later, frozen in liquid nitrogen and stored at -80°C until further use.
For purification, cells were resuspended with buffer A (50 mM Tris-HCl, pH 7.4, 200 mM NaCl), and then lyzed twice with a French Press. Cell debris was removed by centrifugation (Beckman 70Ti rotor, 55000 rpm, 45 minutes, 4°C). Imidazole was added to the supern atant to a final concentration of 25 mM. The sample was passed through a 0.2 μm filter (Stericup, Millipore) and loaded onto a Ni-NTA column (Qiagen), equilibrated with buffer B (buffer A containing 25 mM imidazole). The resin was washed with buffer B and H7-MSP1D1 was eluted with buffer C (buffer A containing 280 mM imidazole). Fractions containing H7-MSP1D1 were identified by SDS-PAGE (NuPAGE 4-12% Bis-Tris gel, 1xMES running buffer, Invitrogen). Pooled fractions containing H7-MSP1D1 were concentrated using a Centriprep YM-10 device (Millipore); imidazole was then removed by a desalting step (PD10 column, GE Healthcare, equilibrated with buffer A). Purified H7-MSP1D1 was frozen in liquid nitrogen, and stored at -80°C until further use. The protein concentration was determined by measuring the absorbance at 280 nm with a NanoDrop 1000 spectrophotometer (version 3.6.0, Thermo Scientific) using a calculated extinction coefficient of 21430 M−1cm−1 and a calculated molecular mass of 24793 Da (ProtParam, ExPASy, http://www.expasy.ch/tools/protparam.html). The protein content was also determined by the method of Schaffner and Weissmann85 with bovine serum albumin as the standard. The identity of H7-MSP1D1 was confirmed by N-terminal sequencing (GHHHHHHHDYDIPTTENLYFQGSTF).
Prior to reconstitution, the H7-tag was removed from H7-MSP1D1 by incubation with Tev protease (150:1 M/M H7-MSP1D1/Tev protease) at room temperature for 1.5 hours. The sample was then incubated with Talon resin (Clontech Laboratories) for 1 hour at 4°C. MSP1D1 was recovered from the flow-through and the subsequent wash with buffer D (buffer A containing 20 mM imidazole). The protein concentration was determined by measuring the absorbance at 280 nm with a NanoDrop 1000 spectrophotometer using a calculated extinction coefficient of 18450 M−1cm−1 and a calculated molecular mass of 22044 Da. MSP1D1 was concentrated in the presence of 2.5 mM cholate to 10-15 mg/ml using an Amicon Ultra-0.5 Ultracel-30 concentrator (Millipore) and used for reconstitution.
Reconstitution and purification of nanodiscs
Nanodisc reconstitutions were performed according to published protocols31,34-36 with modifications. Nanodiscs were prepared using POPC, a POPC/POPG mixture (1:1 M/M), or POPG.
For NTS1f-nanodisc preparations, NTS1f was concentrated to a volume of ~ 200 μl using an Amicon Ultra-0.5 Ultracel-30 concentrator (14000 rpm, 30 min, 4°C, Eppendorf centrifuge). Lipids (solubilized in 50 mM sodium cholate, 50 mM Tris-HCl, pH 7.4, 200 mM NaCl), ice-cold buffer A and concentrated NTS1f were then combined, followed by addition of concentrated MSP1D1. The final concentrations of the components were 3 mM lipids, 3-4 μM NTS1 fusion protein, and 100 μM MSP1D1 in a volume of 1 ml. The mixture was incubated for 1 hour at 4°C. The detergent was then removed by adding 35-fold the weight in cholate of Bio-Beads (SM-2, BioRad). After mixing for 2 hours at 4°C, the Bio-Beads were removed by centrifugation (10000 rpm, 3 min, 4°C, Eppendorf centrifuge). The above procedure generated a mixture of NTS1f-nanodiscs and nanodiscs devoid of receptor. To enrich for NTS1f-nanodiscs, the mixture was incubated in batch for 1 hour at 4°C with 0.3 ml Talon resin (Clontech), equilibrated with buffer D. The resin was transferred into a small column and washed with 4 bed volumes of buffer D. NTS1f-nanodiscs were eluted from the resin in 0.3 ml steps using buffer E (buffer A with 200 mM imidazole). The fractions were analyzed for protein content by measuring the absorbance at 280 nm with a NanoDrop 1000 spectrophotometer using a calculated extinction coefficient of 176185 M−1cm−1 and a calculated combined molecular mass of 144.3 kDa, assuming 2 MSP1D1 molecules and 1 NTS1f molecule per nanodisc. The protein content was also determined by the method of Schaffner and Weissmann85 with bovine serum albumin as the standard. The fraction with the highest NTS1f-nanodisc concentration was used for further experiments.
For production of empty-nanodiscs (nanodiscs without NTS1), the respective lipid/cholate solution, concentrated MSP1D1, and buffer A were mixed to give final concentrations of 5.5 mM lipid and 100 μM MSP1D1 in a volume of 250 μl. The mixture was incubated for 1 hour at 4°C. Bio-Beads were then added for detergent removal to 35-fold of the weight of cholate present in the mixture. After mixing for 2 hours at 4°C, the Bio-Beads were removed by centrifugation (10000 rpm, 3 min, 4°C, Eppendorf centrifuge).
Sedimentation velocity experiments
Sedimentation velocity experiments were conducted at 10.0°C on a Beckman Coulter ProteomeLab XL-I analytical ultracentrifuge. Nanodisc preparations (22 μM empty-nanodiscs, 5-6 μM receptor-nanodiscs) were loaded in 2-channel centerpiece cells and analyzed at a rotor speed of 40 krpm. Absorbance (280 nm) and interference data were collected and analyzed in SEDFIT 12.1b48. Data were also analyzed, individually and globally, in SEDPHAT 8.286 in terms of a continuous c(s) distribution of Lamm equation solutions, as well as hybrid local continuous distributions and global discrete species. In all cases, excellent fits were obtained with absorbance and interference r.m.s.d. values ranging from 0.0050-0.0066 A280 and 0.0060–0.011 fringes. Solution densities ρ and solution viscosities η were measured experimentally at 20.00°C on a Mettler Toledo DE51 density meter and an Anton Paar AMVn rolling ball viscometer, respectively, and corrected to 10.0°C. The partial specific volumes v of MSP1D1 and NTS1f were calculated in SEDNTERP 1.0987. A partial specific volume of 0.979 cm3g−1 was used for both POPC and POPG. This value is based on a published POPC partial specific volume of 0.9952 cm3g−1 at 30.0°C88 and a lipid dv/dT of 0.00080-0.00083 cm3g−1K−1 (refs.89,90). Protein extinction coefficients at 280 nm ε280 were calculated in SEDNTERP 1.09, whereas the interference signal increments εJ were determined using dn/dc values of 0.185 cm3g−1 for MSP1D1 and NTS1f91, and 0.164 cm3g−1 for both POPC and POPG92. Sedimentation coefficients s were corrected to s20,w based on the expected stoichiometries (Table S1).
Dynamic light scattering
The translational diffusion coefficients D and corresponding hydrodynamic radii were measured from an autocorrelation analysis of the quasielastically scattered light at 514.5 nm. Autocorrelation functions were accumulated for 2 to 4 minutes at 19°C and an angle θ of 90° using a Brookhaven Instruments BI-9000 AT autocorrelator with sampling times of 1.0 μsec to 5 msec. Data were imported into SEDFIT 12.1b. For NTS1f-nanodiscs (4-9 μM), the normalized intensity autocorrelation functions g(2)(τ) – 1 were used to obtain the second cumulant Γ2, and moment μ2 (expressed in terms of the polydispersity μ2/Γ2)93,94. In the case of empty-nanodiscs (36-47 μM), the presence of small amounts of aggregate required an analysis of the field autocorrelation function g(1)(τ) = √(g(2)(τ) – 1 in terms of two discrete species.
Lipid analysis by 1H-NMR
POPC and POPG powder was purchased from Avanti Polar Lipids. Deuterated chloroform (CDCl3) and deuterated methanol (MeOD) were obtained from Cambridge Isotope Laboratories. To prepare the reference samples, lipid powder (100 μg) was dissolved in CDCl3 (600 μl) and transferred to a 5 mm OD Precision NMR tube. 100 μl of MeOD was then added. The empty- and NTS1f-nanodisc samples were first freeze-dried, then dissolved in CDCl3 and homogenized by vortexing. Each sample was filtered through a glass wool filter into the NMR tube. The filtration step was necessary to remove chloroform-insoluble salt precipitates and invariably resulted in some small sample losses. 100 μl of MeOD was then added to the samples. 1H-NMR experiments were performed at a resonance frequency of 500.13 MHz on a Bruker DMX500 spectrometer. Spectral assignments were made by reference to published data95. The integrals of the well-isolated peaks of the acyl C2 and C2′ protons (2.25-2.37 ppm) were used for quantification of the total lipid amount. As the peaks specific for the head groups of POPC and POPG were not well isolated in the spectra, we did not analyze the fractional contribution of POPC and POPG in POPC/POPG-nanodiscs.
Lipid analysis by high performance liquid chromatography combined with tandem quadrapole mass spectrometry
The HPLC/MS/MS analyses of empty-POPC-nanodiscs and NTS1f-POPC-nanodiscs were done by Avanti Polar Lipids (one experiment each). Briefly, nanodiscs were diluted into methanol and sonicated to help lipid dissolution. A methanol/ammonium acetate gradient was used for HPLC, followed by MS/MS optimized for POPC. The empty-nanodisc and NTS1f-nanodisc preparations contained 4.5 ± 0.1 mg/ml (5921 μM) POPC and 0.21 ± 0.01 mg/ml (276 μM) POPC, respectively. The corresponding protein content (determined by the method of Schaffner and Weissmann85 was 1.85 mg/ml (84 μM MSP1D1) and 0.6 mg/ml (8.3 μM MSP1D1 and 4.16 μM NTS1f, assuming 2 MSP1D1 molecules and 1 NTS1f molecule per nanodisc). These values correspond to 141 POPC molecules per empty-nanodisc, and 66 POPC molecules per NTS1f-nanodisc.
Saturation and competition agonist binding experiments
NTS1f-nanodiscs, containing receptor with MBP at its N-terminus and a TrxA-H10 tail at its C-terminus, were treated with Tev protease prior to ligand binding and nucleotide exchange experiments, to cleave off the tags and generate NTS1 with near authentic N- and C-termini (Fig. 1, Fig. 4, Fig. S1). For this, purified NTS1f-nanodiscs were incubated with stoichiometric amounts of Tev protease (no DTT addition) for 2 hours on ice; the completeness of the digest was confirmed by SDS-PAGE.
NTS1-nanodiscs were incubated with 3H-NT and unlabeled NT on ice for 1 hour in 150 μl of assay buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 7 mM NaCl, 0.1% BSA, 0.004% bacitracin). Separation of the receptor-ligand complex from free ligand (100 μl) was achieved by centrifugation-assisted gel filtration using Bio-Spin 30 Tris columns (BioRad), equilibrated with RDB buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.1% n-dodecyl-β-D-maltopyranoside, 0.2% CHAPS, 0.04% cholesteryl hemisuccinate Tris salt).
For saturation binding experiments at equilibrium, the 3H-NT concentration was varied from 0.05 nM – 12 nM. Non-specific 3H-NT binding was determined in the presence of 50 μM unlabeled NT. Data were analyzed by nonlinear regression using GraphPad Prism software (version 4, GraphPad Software) and best fit to a one-site binding equation (accounting for ligand depletion) to determine the equilibrium dissociation constants (Kd). Individual experiments were conducted in duplicates.
3H-NT at 2 nM was utilized for homologous competition experiments (NT/3H-NT). Independent experiments were carried out in singles. Ligand depletion was considered to be low (<26%). Data were best fit to a sigmoidal dose-response equation with standard slope using the concentrations of total NT added vs. bound 3H-NT. Inhibition constant (Ki) values were derived from IC50 values using the Cheng and Prusoff equation, Ki = IC50/(1+L/Kd), where L is the concentration of 3H-NT96.
Single-point ligand binding experiments in the presence of 2 nM 3H-NT were conducted to monitor NTS1 during the reconstitution process. A 3H-NT concentration of 5 nM was used to confirm the receptor density in NTS1-nanodisc preparations prior to each nucleotide exchange reaction.
GDP/GTPγS exchange assay
The receptor-catalyzed exchange of GDP for GTPγS on Gαq was determined as previously described97,98 in a total assay volume of 50 μl. Reaction mixtures were kept on ice throughout the procedure unless indicated otherwise. NTS1-nanodiscs were added to G protein (Sepia Gαq and bovine Gβ1γ1) and agonist to give a volume of 30 μl. GDP/GTPγS exchange was initiated by the addition of 20 μl of 35S-GTPγS mix. The final component concentrations in each sample were 50 mM Mops (pH 7.5), 1 mM EDTA, 7 mM NaCl (NT saturation) or 100 mM NaCl (Gαq and Gβ1γ1 saturation), 1 mM DTT, 3 mM MgSO4, 0.3% (wt/vol) BSA, 1 μM GDP, 4-8 nM 35S-GTPγS (Perkin-Elmer), 40 μM adenylyl imidodiphosphate, and 0.4 mM cytidine 5′-monophosphate. Reactions were terminated by diluting the reaction mixture with 2 ml of ice-cold stop buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 25 mM MgCl2) and were filtered over nitrocellulose membranes on a vacuum manifold. Filters were then washed six times with 2 ml of ice-cold stop buffer. The nitrocellulose membranes were dried, and the radioactivity quantitated by liquid scintillation in a Beckman Coulter LS 6500 scintillation counter. Note that Gαq was purified in buffer containing CHAPS. However, the Gαq concentrations in the exchange assays did not exceed 1 μM (see below), thus limiting the free CHAPS concentration to less than 1/10th of its critical micellar concentration50.
Single-point individual experiments were conducted using incubation times of 120 min, 45 min, and 15 min for NTS1 in POPC-, POPC/POPG- and POPG-nanodiscs, respectively (NT saturation, Fig. 5d-f; Gαq saturation, Fig. 6a; Gβ1γ1 saturation, Fig. 6b). NT saturation experiments were conducted at 250 nM Gαq, 1 μM Gβ1γ1, 5 nM NTS1, and 0-1 μM NT. Gαq saturation experiments were done at 0-1 μM Gαq, 1 μM Gβ1γ1, 5 nM NTS1, and 10 μM NT. Gβ1γ1 saturation experiments were done at 250 nM Gαq, 0-5 μM Gβ1γ1, 5 nM NTS1, and 10 μM NT. The fractional contribution of the non-catalyzed nucleotide exchange in Gαq and Gβ1γ1 saturation experiments was estimated from reactions without NT.
For NT saturation experiments, initial rates of reaction were approximated throughout i.e. <54% of 35S-GTPγS was consumed at the highest agonist concentration (Fig. 5d-f). In Gαq and Gβ1γ1 saturation experiments (Fig. 6), <33% and <28% of 35S-GTPγS was consumed, respectively.
Data from NT saturation of NTS1-catalyzed GDP/GTPγS exchange experiments (Fig. 5d-f) were analyzed in terms of a standard sigmoidal dose-response (Hill slope = 1) in GraphPad Prism. For the determination of Km values for Gαq saturation of NT-induced, receptor-catalyzed GDP/GTPγS exchange (Fig. 6), 35S-GTPγS binding in the absence of NT (i.e. the non-catalyzed nucleotide exchange at a given Gαq concentration) was subtracted from 35S-GTPγS binding in the presence of NT. The resulting data, reflecting specific NT-induced nucleotide exchange, were analyzed using a one-site binding equation.
To facilitate the comparison between the three NTS1-nanodisc types (note that different incubation times were chosen for POPC-, POPC/POPG- and POPG-nanodiscs, respectively, to allow robust nucleotide exchange but avoid 35S-GTPγS depletion at an NTS1 concentration of 5 nM), the data from the Gαq, Gβ1γ1, and NT saturation experiments were normalized to catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1 by dividing the measured cpm values through the respective incubation time (min) and 5 (nM). This normalization procedure was done for the highest Gαq, Gβ1γ1, and NT concentrations used in the respective assays (Gαq saturation: 1 μM Gαq, 1 μM Gβ1γ1, 100 mM NaCl, 10 μM NT; Gβ1γ1 saturation: 250 nM Gαq, 5 μM Gβ1γ1, 100 mM NaCl, 10 μM NT; NT saturation: 250 nM Gαq, 1 μM Gβ1γ1, 7 mM NaCl, 1 μM NT) (Table 3). Note that the affinity of NT for NTS1 is affected by the presence of Na+ ions99,100 reducing the efficacy of G protein activation at high NaCl concentrations. Likewise, the data in Fig. 6a and 6b were normalized to catalyzed 35S-GTPγS bound (cpm) (nM NTS1 protein)−1 min−1 to emphasize the effect of the negatively charged lipid POPG on the NTS1-catalyzed nucleotide exchange (Fig. 6c and 6d).
To determine whether the presence of the TrxA-H10 tag at the receptor C-terminus hinders G protein coupling to NTS1, nucleotide exchange experiments were conducted with NTS1f-POPC-nanodiscs in the presence (stoichiometric amounts) and absence of Tev protease (20 nM NTS1, 250 nM Gαq, 1 μM Gβ1γ1, ± 10 μM NT, 100 mM NaCl, 5 min at 30°C) (Fig. 4).
Supplementary Material
Acknowledgements
N-terminal protein sequence analysis was done at the Center for Biologics Evaluation and Research (Food and Drug Administration, Bethesda, MD, USA). DNA sequence analysis was performed by the NINDS DNA Sequencing Facility. We thank Klaus Gawrisch and Walter Teague (NIAAA) for access to the NMR facility and for help; and David Sibley (NINDS), Jürgen Wess (NIDDK), Klaus Gawrisch (NIAAA), and Paul Randazzo (NCI) for critical comments. This research was supported by the Intramural Research Program of the NIH (SI, JFW, JJ, RGr: National Institute of Neurological Disorders and Stroke; RGh: National Institute of Diabetes and Digestive and Kidney Diseases; JKN: National Institute on Deafness and Other Communication Disorders).
Footnote/Abbreviations
- 3H-NT
3H-neurotensin
- CDCl3
deuterated chloroform
- CHAPS
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid
- DLS
dynamic light scattering
- EDTA
ethylenediaminetetraacetate
- GPCR
G protein-coupled receptor
- H7
heptahistidine
- H10
decahistidine
- MBP
E. coli maltose-binding protein
- MeOD
deuterated methanol
- MSP
membrane scaffold protein
- MSP1D1
N-terminally truncated membrane scaffold protein 1
- NT
neurotensin
- NTS1
rat neurotensin type 1 receptor
- NTS1f
NTS1 fusion protein
- POPC
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
- POPG
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
- ROS
rod outer segment
- Tev
tobacco etch virus
- TrxA
E. coli thioredoxin
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Lee AG. Biological membranes: the importance of molecular detail. Trends Biochem. Sci. 2011;36:493–500. doi: 10.1016/j.tibs.2011.06.007. [DOI] [PubMed] [Google Scholar]
- 2.Phillips R, Ursell T, Wiggins P, Sens P. Emerging roles for lipids in shaping membrane-protein function. Nature. 2009;459:379–385. doi: 10.1038/nature08147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th Edition W.H. Freeman and Company; New York: 2002. [Google Scholar]
- 4.Alemany R, Perona JS, Sanchez-Dominguez JM, Montero E, Canizares J, Bressani R, et al. G protein-coupled receptor systems and their lipid environment in health disorders during aging. Biochim. Biophys. Acta. 2007;1768:964–975. doi: 10.1016/j.bbamem.2006.09.024. [DOI] [PubMed] [Google Scholar]
- 5.Gether U, Kobilka BK. G Protein-coupled receptors II. Mechanism of agonist activation. J. Biol. Chem. 1998;273:17979–17982. doi: 10.1074/jbc.273.29.17979. [DOI] [PubMed] [Google Scholar]
- 6.Ji TH, Grossmann M, Ji I. G protein-coupled receptors I. Diversity of receptor-ligand interactions. J. Biol. Chem. 1998;273:17299–17302. doi: 10.1074/jbc.273.28.17299. [DOI] [PubMed] [Google Scholar]
- 7.Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol. Medicine. 2011;17:126–139. doi: 10.1016/j.molmed.2010.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jastrzebska B, Debinski A, Filipek S, Palczewski K. Role of membrane integrity on G protein-coupled receptors: rhodopsin stability and function. Prog. Lipid Res. 2011;50:267–277. doi: 10.1016/j.plipres.2011.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Boesze-Battaglia K, Schimmel R. Cell membrane lipid composition and distribution: implications for cell function and lessons learned from photoreceptors and platelets. J. Exp. Biol. 1997;200:2927–2936. doi: 10.1242/jeb.200.23.2927. [DOI] [PubMed] [Google Scholar]
- 10.Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 1983;22:79–131. doi: 10.1016/0163-7827(83)90004-8. [DOI] [PubMed] [Google Scholar]
- 11.Carraway R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 1973;248:6854–6861. [PubMed] [Google Scholar]
- 12.Leeman SE, Carraway RE. Neurotensin: discovery, isolation, characterization, synthesis and possible physiological roles. Ann. N.Y. Acad. Sci. 1982;400:1, 16. doi: 10.1111/j.1749-6632.1982.tb31557.x. [DOI] [PubMed] [Google Scholar]
- 13.Bissette G, Nemeroff CB, Loosen PT, Prange AJ, Jr., Lipton MA. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature. 1976;262:607–609. doi: 10.1038/262607a0. [DOI] [PubMed] [Google Scholar]
- 14.Clineschmidt BV, McGuffin JC, Bunting PB. Neurotensin: antinocisponsive action in rodents. Eur. J. Pharmacol. 1979;54:129–139. doi: 10.1016/0014-2999(79)90415-1. [DOI] [PubMed] [Google Scholar]
- 15.Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides. 2006;27:2445–2460. doi: 10.1016/j.peptides.2006.04.030. [DOI] [PubMed] [Google Scholar]
- 16.Binder EB, Kinkead B, Owens MJ, Nemeroff CB. Neurotensin and dopamine interactions. Pharmacol. Rev. 2001;53:453–486. [PubMed] [Google Scholar]
- 17.Schimpff R-M, Avard C, Fénelon G, Lhiaubet A-M, Tennezé L, Vidailhet M, et al. Increased plasma neurotensin concentrations in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry. 2001;70:784–786. doi: 10.1136/jnnp.70.6.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tanaka K, Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 1990;4:847–854. doi: 10.1016/0896-6273(90)90137-5. [DOI] [PubMed] [Google Scholar]
- 19.Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J, Delpech B, et al. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett. 1996;386:91–94. doi: 10.1016/0014-5793(96)00397-3. [DOI] [PubMed] [Google Scholar]
- 20.Mazella J, Botto JM, Guillemare E, Coppola T, Sarret P, Vincent JP. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 1996;16:5613–5620. doi: 10.1523/JNEUROSCI.16-18-05613.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mazella J. Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cell. Signal. 2001;13:1–6. doi: 10.1016/s0898-6568(00)00130-3. [DOI] [PubMed] [Google Scholar]
- 22.Kitabgi P. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Curr. Opin. Drug Discov. Devel. 2002;5:764–776. [PubMed] [Google Scholar]
- 23.Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 1999;20:302–309. doi: 10.1016/s0165-6147(99)01357-7. [DOI] [PubMed] [Google Scholar]
- 24.Barroso S, Richard F, Nicolas-Ethève D, Reversat JL, Bernassau JM, Kitabgi P, et al. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. J. Biol. Chem. 2000;275:328–336. doi: 10.1074/jbc.275.1.328. [DOI] [PubMed] [Google Scholar]
- 25.Kitabgi P. Functional domains of the subtype 1 neurotensin receptor (NTS1) Peptides. 2006;27:2461, 2468. doi: 10.1016/j.peptides.2006.02.013. [DOI] [PubMed] [Google Scholar]
- 26.Pang YP, Cusack B, Groshan K, Richelson E. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13) J. Biol. Chem. 1996;271:15060–15068. doi: 10.1074/jbc.271.25.15060. [DOI] [PubMed] [Google Scholar]
- 27.White JF, Grodnitzky J, Louis JM, Trinh LB, Shiloach J, Gutierrez J, et al. Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction. Proc. Natl. Acad. Sci. USA. 2007;104:12199–12204. doi: 10.1073/pnas.0705312104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Harding PJ, Attrill H, Boehringer J, Ross S, Wadhams GH, Smith E, et al. Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers. Biophys. J. 2009;96:964–973. doi: 10.1016/j.bpj.2008.09.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Serebryany E, Zhu GA, Yan EC. Artificial membrane-like environments for in vitro studies of purified G-protein coupled receptors. Biochim. Biophys. Acta. 2012;1818:225–233. doi: 10.1016/j.bbamem.2011.07.047. [DOI] [PubMed] [Google Scholar]
- 30.Ritchie TK, Grinkova YV, Bayburt TH, Denisov IG, Zolnerciks JK, Atkins WM, et al. Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 2009;464:211–231. doi: 10.1016/S0076-6879(09)64011-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Banerjee S, Huber T, Sakmar TP. Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles. J. Mol. Biol. 2008;377:1067–1081. doi: 10.1016/j.jmb.2008.01.066. [DOI] [PubMed] [Google Scholar]
- 32.Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J. Biol. Chem. 2007;282:14875–14881. doi: 10.1074/jbc.M701433200. [DOI] [PubMed] [Google Scholar]
- 33.Knepp AM, Grunbeck A, Banerjee S, Sakmar TP, Huber T. Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands. Biochemistry. 2011;50:502–511. doi: 10.1021/bi101059w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kuszak AJ, Pitchiaya S, Anand JP, Mosberg HI, Walter NG, Sunahara RK. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J. Biol. Chem. 2009;284:26732–26741. doi: 10.1074/jbc.M109.026922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Leitz AJ, Bayburt TH, Barnakov AN, Springer BA, Sligar SG. Functional reconstitution of beta2-adrenergic receptors utilizing self-assembling nanodisc technology. Biotechniques. 2006;40:601–610. doi: 10.2144/000112169. [DOI] [PubMed] [Google Scholar]
- 36.Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. USA. 2007;104:7682–7687. doi: 10.1073/pnas.0611448104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Whorton MR, Jastrzebska B, Park PS, Fotiadis D, Engel A, Palczewski K, et al. Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J. Biol. Chem. 2008;283:4387–4394. doi: 10.1074/jbc.M703346200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yao XJ, Velez Ruiz G, Whorton MR, Rasmussen SG, DeVree BT, Deupi X, et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc. Natl. Acad. Sci. USA. 2009;106:9501–9506. doi: 10.1073/pnas.0811437106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yoshiura C, Kofuku Y, Ueda T, Mase Y, Yokogawa M, Osawa M, et al. NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers. J. Am. Chem. Soc. 2010;132:6768–6777. doi: 10.1021/ja100830f. [DOI] [PubMed] [Google Scholar]
- 40.Boggs JM, Tummler B. Interdigitated gel phase bilayers formed by unsaturated synthetic and bacterial glycerolipids in the presence of polymyxin B and glycerol. Biochim. Biophys. Acta. 1993;1145:42–50. doi: 10.1016/0005-2736(93)90379-e. [DOI] [PubMed] [Google Scholar]
- 41.Davis PJ, Fleming BD, Coolbear KP, Keough KM. Gel to liquid-crystalline transition temperatures of water dispersions of two pairs of positional isomers of unsaturated mixed-acid phosphatidylcholines. Biochemistry. 1981;20:3633–3636. doi: 10.1021/bi00515a051. [DOI] [PubMed] [Google Scholar]
- 42.Dowhan W, Bogdanov M, Mileykovskaya E. Functional roles of lipids in membranes. In: Vance DE, Vance JE, editors. Biochemistry of Lipids, Lipoproteins and Membranes. Elsevier; 2008. pp. 1–37. [Google Scholar]
- 43.Mattai J, Hauser H, Demel RA, Shipley GG. Interactions of metal ions with phosphatidylserine bilayer membranes: effect of hydrocarbon chain unsaturation. Biochemistry. 1989;28:2322–2330. doi: 10.1021/bi00431a051. [DOI] [PubMed] [Google Scholar]
- 44.White JF, Trinh LB, Shiloach J, Grisshammer R. Automated large-scale purification of a G protein-coupled receptor for neurotensin. FEBS Lett. 2004;564:289–293. doi: 10.1016/S0014-5793(04)00195-4. [DOI] [PubMed] [Google Scholar]
- 45.Bayburt TH, Sligar SG. Membrane protein assembly into nanodiscs. FEBS Lett. 2010;584:1721–1727. doi: 10.1016/j.febslet.2009.10.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.le Maire M, Arnou B, Olesen C, Georgin D, Ebel C, Moller JV. Gel chromatography and analytical ultracentrifugation to determine the extent of detergent binding and aggregation, and Stokes radius of membrane proteins using sarcoplasmic reticulum Ca2+ ATPase as an example. Nature Protocols. 2008;3:1782–1795. doi: 10.1038/nprot.2008.177. [DOI] [PubMed] [Google Scholar]
- 47.Nury H, Manon F, Arnou B, le Maire M, Pebay-Pevroula E, Ebel C. Mitochondrial bovine ADP/ATP carrier in detergent is predominantly monomeric but also forms multimeric species. Biochemistry. 2008;47:12319–12331. doi: 10.1021/bi801053m. [DOI] [PubMed] [Google Scholar]
- 48.Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 2000;78:1606–1619. doi: 10.1016/S0006-3495(00)76713-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tanford C. Physical chemistry of macromolecules. John Wiley & Sons; New York: 1961. pp. 356–384. [Google Scholar]
- 50.Chattopadhyay A, Harikumar KG. Dependence of critical micelle concentration of a zwitterionic detergent on ionic strength: implications in receptor solubilization. FEBS Lett. 1996;391:199–202. doi: 10.1016/0014-5793(96)00733-8. [DOI] [PubMed] [Google Scholar]
- 51.Brown MF. Modulation of rhodopsin function by properties of the membrane bilayer. Chem. Phys. Lipids. 1994;73:159–180. doi: 10.1016/0009-3084(94)90180-5. [DOI] [PubMed] [Google Scholar]
- 52.Bubis J. Effect of detergents and lipids on transducin photoactivation by rhodopsin. Biol. Res. 1998;31:59–71. [PubMed] [Google Scholar]
- 53.Gawrisch K, Soubias O, Mihailescu M. Insights from biophysical studies on the role of polyunsaturated fatty acids for function of G-protein coupled membrane receptors. Prostaglandins Leukot. Essent. Fatty Acids. 2008;79:131–134. doi: 10.1016/j.plefa.2008.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jastrzebska B, Goc A, Golczak M, Palczewski K. Phospholipids are needed for the proper formation, stability, and function of the photoactivated rhodopsin-transducin complex. Biochemistry. 2009;48:5159–5170. doi: 10.1021/bi900284x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Kaya AI, Thaker TM, Preininger AM, Iverson TM, Hamm HE. Coupling efficiency of rhodopsin and transducin in bicelles. Biochemistry. 2011;50:3193–3203. doi: 10.1021/bi200037j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Soubias O, Gawrisch K. The role of the lipid matrix for structure and function of the GPCR rhodopsin. Biochim. Biophys. Acta. 2012;1818:234–240. doi: 10.1016/j.bbamem.2011.08.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Wang Y, Botelho AV, Martinez GV, Brown MF. Electrostatic properties of membrane lipids coupled to metarhodopsin II formation in visual transduction. J. Am. Chem. Soc. 2002;124:7690–7701. doi: 10.1021/ja0200488. [DOI] [PubMed] [Google Scholar]
- 58.Bayburt TH, Vishnivetskiy SA, McLean MA, Morizumi T, Huang CC, Tesmer JJ, et al. Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J. Biol. Chem. 2011;286:1420–1428. doi: 10.1074/jbc.M110.151043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Tsukamoto H, Sinha A, DeWitt M, Farrens DL. Monomeric rhodopsin is the minimal functional unit required for arrestin binding. J. Mol. Biol. 2010;399:501–511. doi: 10.1016/j.jmb.2010.04.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Aveldano MI. Phospholipid solubilization during detergent extraction of rhodopsin from photoreceptor disk membranes. Arch. Biochem. Biophys. 1995;324:331–343. doi: 10.1006/abbi.1995.0046. [DOI] [PubMed] [Google Scholar]
- 61.Calvert PD, Govardovskii VI, Krasnoperova N, Anderson RE, Lem J, Makino CL. Membrane protein diffusion sets the speed of rod phototransduction. Nature. 2001;411:90–94. doi: 10.1038/35075083. [DOI] [PubMed] [Google Scholar]
- 62.Denisov IG, Grinkova YV, Lazarides AA, Sligar SG. Directed self-assembly of monodisperse phospholipid bilayer nanodiscs with controlled size. J. Am. Chem. Soc. 2004;126:3477–3487. doi: 10.1021/ja0393574. [DOI] [PubMed] [Google Scholar]
- 63.Denisov IG, McLean MA, Shaw AW, Grinkova YV, Sligar SG. Thermotropic phase transition in soluble nanoscale lipid bilayers. J. Phys. Chem. B. 2005;109:15580–15588. doi: 10.1021/jp051385g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Shaw AW, McLean MA, Sligar SG. Phospholipid phase transitions in homogeneous nanometer scale bilayer discs. FEBS Lett. 2004;556:260–264. doi: 10.1016/s0014-5793(03)01400-5. [DOI] [PubMed] [Google Scholar]
- 65.Matsuda T, Takao T, Shimonishi Y, Murata M, Asano T, Yoshizawa T, et al. Characterization of interactions between transducin alpha/beta gamma-subunits and lipid membranes. J. Biol. Chem. 1994;269:30358–30363. [PubMed] [Google Scholar]
- 66.Seitz HR, Heck M, Hofmann KP, Alt T, Pellaud J, Seelig A. Molecular determinants of the reversible membrane anchorage of the G-protein transducin. Biochemistry. 1999;38:7950–7960. doi: 10.1021/bi990298+. [DOI] [PubMed] [Google Scholar]
- 67.Bigay J, Faurobert E, Franco M, Chabre M. Roles of lipid modifications of transducin subunits in their GDP-dependent association and membrane binding. Biochemistry. 1994;33:14081–14090. doi: 10.1021/bi00251a017. [DOI] [PubMed] [Google Scholar]
- 68.Fukada Y, Matsuda T, Kokame K, Takao T, Shimonishi Y, Akino T, et al. Effects of carboxyl methylation of photoreceptor G protein gamma-subunit in visual transduction. J. Biol. Chem. 1994;269:5163–5170. [PubMed] [Google Scholar]
- 69.Murray D, McLaughlin S, Honig B. The role of electrostatic interactions in the regulation of the membrane association of G protein beta gamma heterodimers. J. Biol. Chem. 2001;276:45153–45159. doi: 10.1074/jbc.M101784200. [DOI] [PubMed] [Google Scholar]
- 70.Soubias O, Teague WE, Jr., Hines KG, Mitchell DC, Gawrisch K. Contribution of membrane elastic energy to rhodopsin function. Biophys. J. 2010;99:817–824. doi: 10.1016/j.bpj.2010.04.068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Beck M, Siebert F, Sakmar TP. Evidence for the specific interaction of a lipid molecule with rhodopsin which is altered in the transition to the active state metarhodopsin II. FEBS Lett. 1998;436:304–308. doi: 10.1016/s0014-5793(98)01156-9. [DOI] [PubMed] [Google Scholar]
- 72.Elgeti M, Kazmin R, Heck M, Morizumi T, Ritter E, Scheerer P, et al. Conserved Tyr223(5.58) plays different roles in the activation and G-protein interaction of rhodopsin. J. Am. Chem. Soc. 2011;133:7159–7165. doi: 10.1021/ja200545n. [DOI] [PubMed] [Google Scholar]
- 73.Hessel E, Muller P, Herrmann A, Hofmann KP. Light-induced reorganization of phospholipids in rod disc membranes. J. Biol. Chem. 2001;276:2538–2543. doi: 10.1074/jbc.M009061200. [DOI] [PubMed] [Google Scholar]
- 74.Madathil S, Fahmy K. Lipid protein interactions couple protonation to conformation in a conserved cytosolic domain of G protein-coupled receptors. J. Biol. Chem. 2009;284:28801–28809. doi: 10.1074/jbc.M109.002030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 2008;16:897–905. doi: 10.1016/j.str.2008.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Gibson NJ, Brown MF. Role of phosphatidylserine in the MI-MII equilibrium of rhodopsin. Biochem. Biophys. Res. Comm. 1991;176:915–921. doi: 10.1016/s0006-291x(05)80273-6. [DOI] [PubMed] [Google Scholar]
- 77.Kimura T, Yeliseev AA, Vukoti K, Rhodes SD, Cheng K, Rice KC, et al. Recombinant cannabinoid type 2 (CB2) receptor in liposome model activates G protein in response to anionic lipid constituents. J. Biol. Chem. 2011 doi: 10.1074/jbc.M111.268425. epub. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Mahalingam M, Martinez-Mayorga K, Brown MF, Vogel R. Two protonation switches control rhodopsin activation in membranes. Proc. Natl. Acad. Sci. USA. 2008;105:17795–17800. doi: 10.1073/pnas.0804541105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Kapust RB, Tozser J, Fox JD, Anderson DE, Cherry S, Copeland TD, et al. Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng. 2001;14:993–1000. doi: 10.1093/protein/14.12.993. [DOI] [PubMed] [Google Scholar]
- 80.Hartman JL, IV, Northup JK. Functional reconstitution in situ of 5-hydroxytryptamine 2c (5HT2c) receptors with alphaq and inverse agonism of 5HT2c receptor antagonists. J. Biol. Chem. 1996;271:22591–22597. doi: 10.1074/jbc.271.37.22591. [DOI] [PubMed] [Google Scholar]
- 81.Papermaster DS, Dreyer WJ. Rhodopsin content in the outer segment membranes of bovine and frog retinal rods. Biochemistry. 1974;13:2438–2444. doi: 10.1021/bi00708a031. [DOI] [PubMed] [Google Scholar]
- 82.Fawzi AB, Northup JK. Guanine nucleotide binding characteristics of transducin: essential role of rhodopsin for rapid exchange of guanine nucleotides. Biochemistry. 1990;29:3804–3812. doi: 10.1021/bi00467a030. [DOI] [PubMed] [Google Scholar]
- 83.Kuhn H, Bennett N, Michel-Villaz M, Chabre M. Interactions between photoexcited rhodopsin and GTP-binding protein: kinetic and stoichiometric analyses from light-scattering changes. Proc. Natl. Acad. Sci. USA. 1981;78:6873–6877. doi: 10.1073/pnas.78.11.6873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Yamazaki A, Tatsumi M, Bitensky MW. Purification of rod outer segment GTP-binding protein subunits and cGMP phosphodiesterase by single-step column chromatography. Methods Enzymol. 1988;159:702–710. doi: 10.1016/0076-6879(88)59065-1. [DOI] [PubMed] [Google Scholar]
- 85.Schaffner W, Weissmann C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 1973;56:502–514. doi: 10.1016/0003-2697(73)90217-0. [DOI] [PubMed] [Google Scholar]
- 86.Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal. Biochem. 2003;320:104–124. doi: 10.1016/s0003-2697(03)00289-6. [DOI] [PubMed] [Google Scholar]
- 87.Hayes DB, Laue T, Philo J. 2008 http://www.jphilo.mailway.com.
- 88.Greenwood AI, Tristram-Nagle S, Nagle JF. Partial molecular volumes of lipids and cholesterol. Chem. Phys. Lipids. 2006;143:1–10. doi: 10.1016/j.chemphyslip.2006.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Nagle JF, Wilkinson DA. Lecithin bilayers. Density measurement and molecular interactions. Biophys. J. 1978;23:159–175. doi: 10.1016/S0006-3495(78)85441-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Tristram-Nagle S, Petrache HI, Nagle JF. Structure and interactions of fully hydrated dioleoylphosphatidylcholine bilayers. Biophys. J. 1998;75:917–925. doi: 10.1016/S0006-3495(98)77580-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Padrick SB, Deka RK, Chuang JL, Wynn RM, Chuang DT, Norgard MV, et al. Determination of protein complex stoichiometry through multisignal sedimentation velocity experiments. Anal. Biochem. 2010;407:89–103. doi: 10.1016/j.ab.2010.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Stora T, Dienes Z, Vogel H, Dusch C. Histidine-tagged amphiphiles for the reversible formation of lipid bilayer aggregates on chelator-functionalized gold surfaces. Langmuir. 2000;16:5471–5478. [Google Scholar]
- 93.Frisken BJ. Revisiting the method of cumulants for the analysis of dynamic light-scattering data. Appl. Opt. 2001;40:4087–4091. doi: 10.1364/ao.40.004087. [DOI] [PubMed] [Google Scholar]
- 94.Koppel DE. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Physics. 1972;57:4814–4820. [Google Scholar]
- 95.Gunstone FD, Harwood JL, Padley FB. The Lipid Handbook. Chapman and Hall/CRC; 1994. [Google Scholar]
- 96.Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973;22:3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
- 97.Hellmich MR, Battey JF, Northup JK. Selective reconstitution of gastrin-releasing peptide receptor with G alpha q. Proc. Natl. Acad. Sci. USA. 1997;94:751–756. doi: 10.1073/pnas.94.2.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Jian X, Sainz E, Clark WA, Jensen RT, Battey JF, Northup JK. The bombesin receptor subtypes have distinct G protein specificities. J. Biol. Chem. 1999;274:11573–11581. doi: 10.1074/jbc.274.17.11573. [DOI] [PubMed] [Google Scholar]
- 99.Grisshammer R, Averbeck P, Sohal AK. Improved purification of a rat neurotensin receptor expressed in Escherichia coli. Biochem. Soc. Trans. 1999;27:899–903. doi: 10.1042/bst0270899. [DOI] [PubMed] [Google Scholar]
- 100.Martin S, Botto JM, Vincent JP, Mazella J. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Mol. Pharmacol. 1999;55:210–215. doi: 10.1124/mol.55.2.210. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






